Lenders Call the Shots at Recent Lab Developments
Following an ill-timed development boom, nearly half of the recent lab projects in Greater Boston are now controlled by lenders, according to industry research.
Following an ill-timed development boom, nearly half of the recent lab projects in Greater Boston are now controlled by lenders, according to industry research.
A 240-unit apartment building will replace a 99 Restaurant in Charlestown under an $85 million development by the property’s longtime owner.
Lab developer IQHQ sold another approved development site in Boston, a 3-acre parcel that’s approved for a 409,395 square-foot lab complex, to New Balance’s real estate arm.
A failed Medford lab development provides a stark example of how Massachusetts’ rapidly retreating life sciences market left some developers and lenders high and dry.
A former Massachusetts employee stole company secrets and strategies on lab properties, major life science developer Alexandria Real Estate Equities claims in a lawsuit.
Boston planning officials approved a new hybrid building prototype in Boston’s Newmarket district and $200,000 that Harvard University will donate to local organizations as community benefits associated with its institutional projects in Allston.
Developers plan to build the 636-unit housing portion first at the 1.7-million-square-foot 776 Summer St. project in South Boston, reflecting lack of current demand for 860,000 square feet of approved office and lab space.
Venture capital investment in the U.S. life science industry surged in the second quarter, potentially easing the historic glut of lab space seeking tenants.
At neighborhood meetings last fall, residents objected to Rafi Properties’ proposed building heights of up to 245 feet, plans for 1,252 parking spaces and loss of arts and cultural space.
A contaminated industrial site near Wellington Circle would be redeveloped as a lab complex under a proposal by an Acton developer.
After a series of high-profile dispositions in the Boston area, the nation’s largest life science developer got back in acquisition mode with a $43 million purchase on South Boston’s Dorchester Avenue.
Financial terms of a planned office-lab project in the Boston Seaport District were amended by Massport officials amid an increasingly difficult development landscape.
Greystar’s second Somerville project would include nearly 1.6 million square feet of hotel, office and lab space steps from its nearly-completed 74M tower.
Greater Boston’s 16 million-square-foot lab construction pipeline used to represent an exclamation point for the region’s life science industry. Today, it’s one of the biggest question marks in the local commercial real estate market.
Yes, unbuilt suburban lab projects are unraveling and rents are sinking, but the life science industry is built on real demand and requires in-person work. Life science real estate isn’t going anywhere in Boston.
As developers rethink plans for additional life science projects, Bulfinch Cos. will swap out a planned lab conversion on hold at the Natick Mall in favor of a pickleball complex.
Double-digit availability rates are the new norm for lab space in Greater Boston, with only the industry hub of East Cambridge avoiding the full force of the market downturn.
Moderna’ new global headquarters in Cambridge’s Kendall Square is set for delivery in November under budget, developer Alexandria Real Estate Equities announced.
A vacant industrial property in Watertown would be converted into lab and manufacturing space under plans submitted to Watertown officials by Boston-based Seyon Group this month.
The largest community benefits agreement to support arts and culture in Boston history is the price that a lab developer will pay to replace Brighton’s Sound Museum with a life science campus.